Cargando…

Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy

To provide clinically relevant criteria for differentiation between the athlete’s heart and similar appearing hypertrophic (HCM), dilated (DCM), and arrhythmogenic right-ventricular cardiomyopathy (ARVC) in MRI. 40 top-level athletes were prospectively examined with cardiac MR (CMR) in two universit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kübler, J., Burgstahler, C., Brendel, J. M., Gassenmaier, S., Hagen, F., Klingel, K., Olthof, S.-C., Blume, K., Wolfarth, B., Mueller, K. A. L., Greulich, S., Krumm, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302518/ https://www.ncbi.nlm.nih.gov/pubmed/34019206 http://dx.doi.org/10.1007/s10554-021-02280-6

Ejemplares similares

Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC From Other Arrhythmogenic Cardiomyopathies?
por: Altmayer, Stephan, et al.
Publicado: (2020)

Using Multiparametric Cardiac Magnetic Resonance to Phenotype and Differentiate Biopsy-Proven Chronic from Healed Myocarditis and Dilated Cardiomyopathy
por: Krumm, Patrick, et al.
Publicado: (2022)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice
por: Li, Ka Hou Christien, et al.
Publicado: (2017)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

Prevalence of pathological FFR(CT) values without coronary artery stenosis in an asymptomatic marathon runner cohort
por: Gassenmaier, Sebastian, et al.
Publicado: (2021)

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
por: Li, Mengmeng, et al.
Publicado: (2018)

Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
por: te Riele, Anneline SJM, et al.
Publicado: (2014)

Comprehensive Cardiac Magnetic Resonance to Detect Subacute Myocarditis
por: Brendel, Jan M., et al.
Publicado: (2022)

T1 Mapping MOLLI 5(3)3 Acquisition Scheme Yields High Accuracy in 1.5 T Cardiac Magnetic Resonance
por: Krumm, Patrick, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review
por: Romero, Jorge, et al.
Publicado: (2013)

A classic case of arrhythmogenic right ventricular cardiomyopathy (ARVC) and literature review
por: Latt, Htun, et al.
Publicado: (2017)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

The impact of new proposed arrhythmogenic right ventricular cardiomyopathy (ARVC) criteria on CMR diagnosis
por: Natale, Luigi, et al.
Publicado: (2013)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Value of MRI derived parameters in the discrimination of familial left ventricular noncompaction (LVNC), DCM and HCM in comparison to healthy volunteers
por: Gutberlet, Matthias, et al.
Publicado: (2011)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
por: Scheel, Paul J., et al.
Publicado: (2021)

A Novel Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Biomarker—Anti-DSG2—Is Absent in Athletes With Right Ventricular Enlargement
por: Dorian, David, et al.
Publicado: (2021)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator( )
por: Protonotarios, Alexandros, et al.
Publicado: (2022)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
Publicado: (2022)

Electroanatomical voltage mapping with a force-sensing technology catheter for diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
por: Rossi, V A, et al.
Publicado: (2023)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death
por: Dass, Sairia, et al.
Publicado: (2012)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Brendel, Jan M., et al.
Publicado: (2023)

Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking
por: Heermann, Philipp, et al.
Publicado: (2014)

Long term CMR follow up of patients with right ventricular abnormality and clinically suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Femia, Giuseppe, et al.
Publicado: (2019)

Immunofluorescent Localization of Plakoglobin Is Altered in Endomyocardial Biopsy Samples from Dogs with Clinically Relevant Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
por: Oxford, Eva M., et al.
Publicado: (2021)

Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Aljehani, A., et al.
Publicado: (2023)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice
por: Rehmani, Taha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vhu9imgl420ec0omco2v0cojv2